Previous close | 54.91 |
Open | 54.90 |
Bid | 55.75 x 1800 |
Ask | 0.00 x 800 |
Day's range | 54.72 - 55.74 |
52-week range | 53.70 - 83.25 |
Volume | |
Avg. volume | 10,912,356 |
Market cap | 69.899B |
Beta (5Y monthly) | 0.55 |
PE ratio (TTM) | 9.77 |
EPS (TTM) | 5.70 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | 2.66 (4.78%) |
Ex-dividend date | 19 Apr 2024 |
1y target est | 68.76 |
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
A recent CVS Health® (NYSE: CVS)/Morning Consult survey found that a majority of adults have significant concerns about their mental health and rates across the country continue to rise.
FEATURE Shares of CVS Health just went on sale. But like Valentine’s candy in March, just because something is cheap, that doesn’t make it a good buy. Shares of the convenience-store-turned-health-insurance giant plunged 17% Wednesday after it posted earnings that disappointed investors’ already tempered expectations.